Shownotes
Luca Issi, Senior Biotechnology Research Analyst at RBC Capital Markets, discusses the art of building biopharma breakthroughs with Arjun Goyal, Co-Founder and Managing Director of Vida Ventures.
Key Points
- Maturation of the industry is increasing innovation and capital inflows
- Strong science, management and investors can keep the IPO window open